Active Ingredient History

  • Now
Piromelatine (Neu-P11) is a multimodal sleep drug under development by Neurim Pharmaceuticals. It is an agonist at melatonin MT1/MT2 and serotonin 5-HT1A/5-HT1D receptors. Neurim is conducting a phase II randomized, placebo controlled trial of cognitive and sleep effects in Alzheimer's disease.   Wikipedia

More Chemistry
n-(2-(5-methoxy-indol-3-yl)-ethyl)-4-oxo-4h-pyran-2-carboxamide | neu-p11 | piromelatine


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue